G
C. Cecchini et al.
Feature
Synthesis
LC-MS: m/z calcd for C15H22O6Na [M + Na]+: 321.1; found: 321.2.
IR (neat): 2924, 1737, 1344, 1223, 1160, 1093, 814, 547 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.82–7.80 (m, 3 H), 7.70–7.68 (m, 3 H),
7.50–7.48 (m, 2 H), 7.36–7.31 (m, 3 H), 5.86 (d, J = 7.2 Hz, 1 H), 4.88 (s,
1 H), 4.51 (s, 1 H), 3.86–3.77 (m, 2 H), 3.42–3.41 (m, 2 H), 3.28–3.21
(m, 1 H), 2.44 (s, 3 H), 2.03 (s, 3 H).
13C NMR (101 MHz, CDCl3): δ = 169.7, 143.8, 142.9, 135.7, 133.2,
132.9, 132.8, 127.9, 128.4, 128.1, 127.9, 127.7, 126.4, 126.4, 126.3,
124.3, 110.4, 75.6, 52.5, 50.0, 48.0, 21.6, 21.0.
(4-Methoxyphenyl)(4-methylene-1-tosylpyrrolidin-3-yl)methyl
Acetate (2e)
Product 2e was isolated following GP-1 as a colorless oil (44%, 27 mg,
0.066 mmol, dr 6:4) using 1e (53 mg, 0.15 mmol) as reagent.
IR (neat): 2922, 1737, 1513, 1344, 1227, 1159, 1027, 661 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.3 Hz, 2 H), 7.63 (d, J = 8.3
Hz, 2 H), 7.33 (t, J = 7.9 Hz, 4 H), 7.16 (d, J = 7.9 Hz, 4 H), 6.85–6.82 (m,
4 H), 5.62–5.56 (m, 2 H), 5.04 (d, J = 18.2 Hz, 2 H), 4.87 (d, J = 2.0 Hz, 1
H), 4.47 (d, J = 2.1 Hz, 1 H), 3.88–3.69 (m, 4 H), 3.80 (s, 3 H), 3.78 (s, 3
H), 3.44–3.40 (m, 1 H), 3.33–3.29 (m, 1 H), 3.16–2.96 (m, 4 H), 2.44 (s,
3 H), 1.99 (s, 3 H), 1.98 (s, 3 H).
13C NMR (101 MHz, CDCl3): δ = 169.8 (da), 169.7 (db), 159.7 (da),
159.5 (db), 144.2, 143.8 (da), 143.8 (db), 142.9, 132.8 (da), 132.7 (db),
130.5 (da), 130.0 (db), 129.7 (da), 129.7 (db), 128.7 (da), 128.3 (db),
127.8, 114.0 (da), 113.8 (db), 110.6 (da), 110.3 (db), 75.3 (da), 75.3
(db), 55.3 (da), 55.3 (db), 52.5 (da), 52.1 (db), 50.2 (da), 50.0 (db), 48.3
(da), 48.0 (db), 21.6, 21.1 (da), 21.0 (db).
LC-MS: m/z calcd for C25H25NO4SNa [M + Na]+: 458.1; found: 458.3.
2-(4-Methylene-1-tosylpyrrolidin-3-yl)propan-2-yl Acetate (2i)
Product 2i was isolated following GP-1 as a pale yellow oil (70%, 35
mg, 0.105 mmol) using 1i (41 mg, 0.15 mmol) as reagent. Spectra cor-
respond to the literature.16
1H NMR (300 MHz, CDCl3): δ = 7.68 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 8.0
Hz, 2 H), 5.04 (d, J = 10.6 Hz, 1 H), 3.86 (d, J = 12.1 Hz, 1 H), 3.71 (d, J =
13.7 Hz, 1 H), 3.71 (d, J = 13.7 Hz, 1 H), 3.41 (dd, J = 9.6, 3.1 Hz, 1 H),
3.33–3.31 (m, 1 H), 3.25–3.19 (m, 1 H), 2.42 (s, 3 H), 1.91 (s, 3 H), 1.45
(s, 3 H), 1.46 (s, 3 H).
LC-MS: m/z calcd for C22H25NO5SNa [M + Na]+: 438.1; found: 438.3.
1-(4-Methylene-1-tosylpyrrolidin-3-yl)ethyl Acetate (2j)
(4-Methylene-1-tosylpyrrolidin-3-yl)[3-(trifluoromethyl)phe-
nyl]methyl Acetate (2f)
Product 2j was isolated following GP-1 as a colorless oil (59%, 28 mg,
0.087 mmol) using 1j (35 mg, 0.15 mmol) as reagent.
Product 2f was isolated following GP-1 as a colorless oil (36%, 20 mg,
0.044 mmol) using 1f (59 mg, 0.15 mmol) as reagent.
IR (neat): 2926, 1734, 1372, 1343, 1159, 1092, 662, 547 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.71 (d, J = 8.2 Hz, 2 H), 7.34 (d, J = 8.0
Hz, 2 H), 5.01 (dd, J = 18.6, 2.0 Hz, 2 H), 4.96–4.93 (m, 1 H), 3.85–3.72
(m, 2 H), 3.43 (dd, J = 9.8, 7.9 Hz, 1 H), 3.27–3.23 (m, 1 H), 2.82–2.79
(m, 1 H), 2.43 (s, 3 H), 1.92 (s, 3 H), 1.18 (dd, J = 10.2, 5.9 Hz, 3 H).
13C NMR (101 MHz, CDCl3): δ = 170.1, 143.8, 143.8, 132.8, 129.7,
127.8, 109.4, 70.1, 52.5, 49.3, 47.5, 21.5, 21.0, 17.8.
IR (neat): 2979, 1751, 1329, 1226, 1163, 903, 722, 650 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.2 Hz, 2 H), 7.47–7.33 (m, 6
H), 5.70 (d, J = 7.3 Hz, 1 H), 4.92 (d, J = 1.7 Hz, 1 H), 4.46 (d, J = 1.7 Hz,
1 H), 3.78 (s, J = 6.2 Hz, 2 H), 3.41–3.30 (m, 2 H), 3.12–3.08 (m, 1 H),
2.44 (s, 3 H), 2.02 (s, 3 H).
13C NMR (101 MHz, CDCl3): δ = 169.6, 144.0, 142.5, 139.5, 130.4,
LC-MS: m/z calcd for C16H21NO4SNa [M + Na]+: 346.1; found: 346.2.
129.8, 129.0, 127.8, 127.2, 126.4, 125.2 (q, 2JC,F = 3.7 Hz), 123.5 (q, 3JC,F
1
= 3.7 Hz), 123.0 (d, JC,F = 273 Hz), 110.8, 74.7, 52.3, 49.8, 48.3, 21.5,
6-Methyl-2-(4-methylene-1-tosylpyrrolidin-3-yl)hept-5-en-2-yl
Acetate (2k)
20.9.
19F NMR (376 MHz, CDCl3): δ = –62.7.
LC-MS: m/z calcd for C22H22F3NO4SNa [M + Na]+: 476.1; found: 476.1.
Product 2k was isolated following GP-1 as a pale yellow oil (43%, 26
mg, 0.065 mmol) using 1k (35 mg, 0.15 mmol) as reagent.
IR (neat): 2923, 1734, 1345, 1237, 1160, 1094, 660, 589 cm–1
.
(3-Fluoro-4-methylphenyl)(4-methylene-1-tosylpyrrolidin-3-
yl)methyl Acetate (2g)
1H NMR (300 MHz, CDCl3): δ = 7.70 (d, J = 8.3 Hz, 2 H), 7.33 (d, J = 7.9
Hz, 2 H), 5.05–4.98 (m, 2 H), 3.92–3.67 (m, 2 H), 3.54–3.48 (m, 2 H),
3.23–3.17 (m, 2 H), 2.43 (s, 3 H), 2.06–2.89 (m, 2 H), 1.96 (s, 3 H),
1.81–1.72 (m, 1 H), 1.66 (s, 3 H), 1.67 (s, 3 H), 1.46–1.38 (m, 1 H), 1.31
(s, 3 H).
Product 2g was isolated following GP-1 as a colorless oil (41%, 25 mg,
0.062 mmol) using 1g (52 mg, 0.15 mmol) as reagent.
IR (neat): 2926, 1740, 1371, 1344, 1223, 1160, 662, 588 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.3 Hz, 2 H), 7.33 (d, J = 8.4
Hz, 2 H), 7.11 (t, J = 7.8 Hz, 1 H), 6.90–6.84 (m, 2 H), 5.62 (d, J = 7.1 Hz,
1 H), 4.91 (s, 1 H), 4.54 (s, 1 H), 3.84–3.71 (m, 2 H), 3.39–3.30 (m, 2 H),
3.10–3.06 (m, 1 H), 2.44 (s, 3 H), 2.23 (s, 3 H), 1.99 (s, 3 H).
13C NMR (75 MHz, CDCl3): δ = 170.2, 143.7, 132.5, 132.0, 129.7, 127.8,
127.2, 123.4, 111.5, 85.4, 53.2, 49.6, 49.1, 35.3, 25.7, 22.2, 22.0, 21.5,
20.6, 17.6.
HRMS: m/z calcd for C22H31NO4SNa [M + Na]+: 428.1875; found:
428.1869.
13C NMR (101 MHz, CDCl3): δ = 169.6, 161.1 (d, 1JC,F = 245 Hz), 143.9,
4
142.7, 138.1, 132.7, 131.5 (d, JC,F = 5.3 Hz), 129.7, 127.8, 124.9 (d,
3JC,F = 17 Hz), 122.3 (d, 5JC,F = 3 Hz), 113.3 (d, 2JC,F = 23 Hz), 110.4, 74.6,
52.4, 49.8, 48.1, 21.6, 20.9, 14.3 (d, 6JC,F = 3 Hz).
(3a,7a)-3-Methylene-1-tosyl-2,3,3a,6,7,7a-hexahydro-1H-indole
(4a)
19F NMR (376 MHz, CDCl3): δ = –116.
LC-MS: m/z calcd for C22H24FNO4SNa [M + Na]+: 440.1; found: 440.2.
Product 4a was isolated following GP-2 as a colorless oil (69%, 60.1
mg, 0.21 mmol) using 3a (87 mg, 0.3 mmol) as reagent. Spectroscopic
data correspond to the literature.15
1H NMR (300 MHz, CDCl3): δ = 7.73 (d, J = 8.3 Hz, 2 H), 7.30 (d, J = 8.0
Hz, 2 H), 5.80–5.77 (m, 1 H), 5.65–5.60 (m, 1 H), 4.98 (d, J = 2.2 Hz, 1
H), 4.84 (d, J = 2.3 Hz, 1 H), 4.01–3.84 (m, 3 H), 2.73 (br s, 1 H), 2.42 (s,
3 H), 2.11–1.89 (m, 3 H), 1.63–1.51 (m, 1 H).
(4-Methylene-1-tosylpyrrolidin-3-yl)(naphthalen-2-yl)methyl
Acetate (2h)
Product 2h was isolated following GP-1 as a colorless oil (43%, 28 mg,
0.065 mmol) using 1h (56 mg, 0.15 mmol) as reagent.
Georg Thieme Verlag Stuttgart · New York — Synthesis 2019, 51, A–I